Top 40 UNUM Therapeutics investors
The most complete profiles first. Showing 40 of 42.
David BonitaVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more
Verified email available
Geoffrey HsuVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jernej GodecVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Joshua KennedyVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Kevin BittermanVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more
Verified email available
Stephanie A. SirotaVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsEnterprise SoftwareInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Verified email available
Alex HardingVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Andrew PangVerified
Venture Capital, Private Equity Firm · Hong Kong
Health CareGeneticsWomen FoundedLife SciencePortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Verified email available
Catherine PoulinVerified
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Verified email available
Jason P. HaflerVerified
Corporate Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Verified email available
Jason RhodesVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Jonathan SilversteinVerified
Private Equity Firm · United States
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Jonathan WangVerified
Private Equity Firm · China
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Laia CrespoVerified
Venture Capital, Corporate Venture Capital, Investor · France
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Verified email available
Rishi GuptaVerified
Private Equity Firm · United States
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Verified email available
Ron HuntVerified
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Verified email available
Todd BradyVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: F2G, UNUM Therapeutics, Avidity Biosciences, Avrobio and 10 more
Contact details available
Bruce Booth
Venture Capital, Angel/Individual
SeedHealthcare DeliveryWellnessBiotechnologyConsumer HealthPortfolio: Nimbus Therapeutics, Magenta Therapeutics, Bicycle Therapeutics, Miragen Therapeutics and 13 more
Contact details available
Carter Neild
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Chau Khuong
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more
Contact details available
Naveen Yalamanchi
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Piratip Pratumsuwan
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Roderick Wong
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 29 more
Contact details available
Sabera Loughran
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareGeneticsInvestment ManagementLife SciencePortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Scotland Stevens
Venture Capital, Private Equity Firm, Investor · United States
SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Tony Nguyen
Hedge Fund, Venture Capital, Investor · United States
Series BAdvertisingHealth CareGeneticsInvestment ManagementPortfolio: AveXis, Frequency Therapeutics, Roivant Sciences, Magnolia Medical Technologies and 28 more
Contact details available
Alain J. Gilbert
Private Equity Firm, Investment Partner · France
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Anat Naschitz
Private Equity Firm · Israel
Health CareLife ScienceInformation Technology (IT)MobilePortfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
Barney Han
Venture Capital, Private Equity Firm
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Contact details available
Charles Chon
Venture Capital, Private Equity Firm · Hong Kong
Health CareGeneticsWomen FoundedLife SciencePortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Contact details available
Craig Slutzkin
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Daniel Mansuri
Corporate Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Proteostasis Therapeutics, Science 37, ImmuneXcite, Aetion and 37 more
Contact details available
Erez Chimovits
Private Equity Firm · Israel
Health CareInvestment ManagementLife ScienceInformation Technology (IT)Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more
Contact details available
James Niedel
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Jean
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Jeffrey Ives
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Marc
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Rebecca Luse
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Reese Yeh
Venture Capital, Private Equity Firm
Health CareGeneticsWomen FoundedLife SciencePortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Contact details available
Steven Robinette
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
See all 42 UNUM Therapeutics investors
Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many UNUM Therapeutics investors are on Angel Roster?
Angel Roster lists 42 UNUM Therapeutics investors. 16 of them (38%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (32), Private Equity Firms (24) and Hedge Funds (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do UNUM Therapeutics investors invest in?
Among those that list a stage, the most common are Series B (9), Seed (6) and Series A (5).
Where are UNUM Therapeutics investors based?
Most are based in the United States (29), Israel (2) and Hong Kong (2).
Which companies have UNUM Therapeutics investors backed?
The most-backed portfolio companies among them are Q32 Bio (19), Cogent Biosciences (19), Ventyx Biosciences (17), ReViral (17) and Harbour Biomed (16).
How do I contact UNUM Therapeutics investors?
Create a free Angel Roster account to search and filter all 42, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.